.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer, taking up the best scientific research spot at Sanofi.Quigley will start Sept. 30 as the French Big Pharma's main medical officer and also international director of research, Sanofi said to Brutal Biotech in an emailed statement.Quigley is changing Frank Nestle, M.D., that left behind Sanofi this spring season amidst an international overhaul of the firm's R&D device. Nestle, who devoted eight years along with the pharma, jumped over to Deerfield Management, where he currently serves as a companion on the therapeutics team and chief executive officer of the company's restorative revelation and progression operations.
Quigley will certainly participate in Sanofi coming from a San Francisco-based biotech that remains in stealth, according to his LinkedIn profile page. He is actually presently noted as the company's founder, head of state and CEO.Given that August 2021, Quigley has actually functioned as a project companion at SV Health and wellness Investors, a health care fund manager with current financial investments in biotechs like BioAge, Cerevance, Dualitas Therapeutics and also Nimbus Therapeutics, to name a few. Quigley previously held the leading spot at Dualitas, a biotech that stays in secrecy, according to STAT.The prospective Sanofi leader also formerly helmed Therini Bio, an immunotherapy biotech functioning to establish therapies for neurodegenerative illness steered by vascular dysfunction.Before spending the final few years in biotech, Quigley possesses an even longer performance history in Major Pharma, very most recently functioning as Gilead's elderly vice president of study biology till the summer season of 2021. Before that, he clocked in greater than four years throughout different management roles at Bristol Myers Squibb as well as worked as a clinical supervisor at Johnson & Johnson's Janssen arm before that.Sanofi said Quigley's purpose in his new role would be to "maximize our chance of success through superior cooperations around our association and also past, delivering best-in-class technology in addition to building and also sourcing brand-new industry-leading skill with a dedication to diversity," according to an internal memorandum gotten by STAT.